🔗 Share this article

While the United States proceeds with unprecedented revisions to its vaccine schedules, one figure appears unexpectedly: Dr. Tracy Beth Høeg, a US-based physician and public health researcher who first made her name by questioning coronavirus vaccinations throughout the pandemic and has zeroed in on alleged deaths after Covid immunization in her recent tenure at the Food and Drug Administration.

Scheduled Changes to Childhood Vaccine Program

Public health authorities had intended to unveil radical revisions to the childhood immunization program in December, bringing the US with Denmark’s immunization schedule, according to reports – a major change that would put the US at odds with many the global community with insufficient data for public health gain. This reveal has been delayed until the new year.

Instead of the top vaccines chief, Høeg is set to address the audience at the meeting. She was recently named interim head of the FDA’s CDER, the fifth appointee to lead the division this calendar year.

A New Direction at the Agency

This interim role might represent a strengthened alliance between the drug and biologics divisions as Høeg and Prasad consolidate power at the agency – and it suggests a renewed priority upon rolling back already-approved immunizations at the FDA.

Dr. Høeg has often pushed for ending certain childhood immunization guidelines in the US to become more in line with Denmark's approach, a nation with universal health coverage and a number of inhabitants about the size of Wisconsin’s.

In her initial statements, she has persisted in emphasizing on immunizations – usually the domain of Prasad, chief of the FDA’s CBER – rather than pharmaceutical oversight.

Doubts Over Qualifications

Dr. Høeg has no apparent experience in medication creation, approval processes or management, which has been standard for former heads of the biologics center. She has served at the FDA as a senior adviser to the FDA chief and the vaccine center since March.

“She appears not to have the necessary background” for running the pharmaceutical oversight division, stated a neurologist and psychiatrist. “She lacks experience running a randomized controlled trial. She has no expertise in leading a sizeable institution. She is not an expert in industry regulation.”

Past heads of CBER would “grasp legal statutes and the research of pharmaceutical innovation”, commented Janet Woodcock. “Frankly, she has not acquired the type of experience that prior appointees who led CBER have had.”

This division has an vast range of responsibilities at the agency, the former commissioner stated.

“Many people just pays attention on the novel medication approvals, but the off-patent medication office approves thousands of off-brand pharmaceuticals. There’s a biosimilars division, over-the-counter program and other areas, and every single one must be supervised,” Dr. Woodcock explained. “The area you overlook, that is precisely what that I always told people is going to cause problems.”

Additionally, a major management component to the job, which supervises in excess of 5,000 staff members. “It is a huge administrative position, if you do it right,” the former official concluded.

Response and Controversial Initiatives

When asked about inquiries about Høeg’s qualifications and whether this assignment indicates greater collaboration among agency officials on vaccines, a spokesperson responded that the “questions are based on flawed presumptions”.

“This background is consistent with the responsibilities of her position,” the representative explained, citing the period Dr. Høeg spent advising the agency head on “drug safety and oversight research, including predictive safety algorithms and shot safety tracking”.

As acting director, Høeg takes over the agency head's recently launched expedited review system, a controversial rapid therapy clearance system that allegedly worried her former heads. “How are these therapies being picked for this voucher program? Who takes the choices?” Howard asked. “There’s a lot of confidentiality happening at the FDA right now.”

Broadly speaking, he stated, “the Food and Drug Administration appears to be shifting towards more relaxed rules of most medications, with the exception of shots.”

Documented History on Immunizations

With immunizations, Dr. Høeg has a more established, if concerning, past, some experts have noted. She released a study using non-validated volunteer-provided data to determine the frequency of myocarditis following Covid immunization. She advised the Florida chief medical officer Dr. Joseph Ladapo, who was said to have changed statistics to indicate COVID-19 vaccines are pose a greater threat than they are.

Among her “desired changes” for the current government featured revising regulations for new vaccines and discontinuing “non-essential” immunizations, she said after the election on a audio program. At the agency, Høeg has allegedly suggested barring adolescent males from getting Covid vaccines.

“She is an all-around dogmatist who starts off with her preconceived notions and reverse-engineers to retrofit the data in a highly disingenuous, fraudulent way,” Dr. Howard said.

Taking Control and a “Campaign of Retribution”

Høeg became part of other skeptics, {like|